We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comment on "Psoriasis, COVID‐19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".
- Authors
Farabi, Banu; Bhargava, Shashank; Goldust, Mohamad; Atak, Mehmet Fatih
- Abstract
We have read with great interest the review article published by Magnano et al which was recently published in I Dermatologic Therapy Journal i .1 We found it interesting to expand the discussion in this regard that may be practically helpful for the dermatologists in the era of COVID19 pandemic. It is an area of debate whether it is advisable or not to stop biologic agents in the treatment of psoriasis during COVID-19 pandemic. Novel coronavirus disease (COVID-19) and biologic therapy in psoriasis: infection risk and patient counseling in uncertain times.
- Subjects
ADULT respiratory distress syndrome; COVID-19; PSORIASIS; HIGHLY active antiretroviral therapy; NF-kappa B
- Publication
Dermatologic Therapy, 2020, Vol 33, Issue 6, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.13840